Advisor Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $72K | Buy |
11,139
+3,813
| +52% | +$24.6K | ﹤0.01% | 3162 |
|
|
2019
Q3 | $29K | Sell |
7,326
-74
| -1% | -$293 | ﹤0.01% | 3725 |
|
|
2019
Q2 | $36K | Hold |
7,400
| – | – | ﹤0.01% | 3569 |
|
|
2019
Q1 | $61K | Sell |
7,400
-2,519
| -25% | -$20.8K | ﹤0.01% | 3238 |
|
|
2018
Q4 | $54K | Buy |
9,919
+9,619
| +3,206% | +$52.4K | ﹤0.01% | 3119 |
|
|
2018
Q3 | $3K | Sell |
300
-357
| -54% | -$3.57K | ﹤0.01% | 4711 |
|
|
2018
Q2 | $7K | Sell |
657
-8
| -1% | -$85 | ﹤0.01% | 4221 |
|
|
2018
Q1 | $6K | Sell |
665
-1
| -0.2% | -$9 | ﹤0.01% | 4304 |
|
|
2017
Q4 | $10K | Hold |
666
| – | – | ﹤0.01% | 4063 |
|
|
2017
Q3 | $13K | Buy |
666
+133
| +25% | +$2.6K | ﹤0.01% | 3803 |
|
|
2017
Q2 | $7K | Buy |
533
+262
| +97% | +$3.44K | ﹤0.01% | 4071 |
|
|
2017
Q1 | $2K | Sell |
271
-16
| -6% | -$118 | ﹤0.01% | 4356 |
|
|
2016
Q4 | $3K | Hold |
287
| – | – | ﹤0.01% | 4090 |
|
|
2016
Q3 | $2K | Buy |
287
+97
| +51% | +$676 | ﹤0.01% | 4129 |
|
|
2016
Q2 | $1K | Buy |
+190
| New | +$1K | ﹤0.01% | 4185 |
|